Evidence map›Paper›PMID 40980411›Full record

SynthesisFrontiers in health services2025

COVID-19 vaccine hesitancy in Ethiopia: a scoping review for equitable vaccine access.

Senait Aleamyehu Beshah, Jibril Bashir Adem, Mosisa Bekele Degefa, Melkamu Ayalew, Yohannes Lakew, Sileshi Garoma, Elizabeth Naa Adukwei Adote, Daniel Malik Achala, Grace Njeri Muriithi, Chinyere Ojiugo Mbachu and 5 more

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in health services, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Senait Aleamyehu BeshahAfrican Health Economics and Policy Association (AfHEA), Accra, Ghana.
Jibril Bashir AdemDepartment of Public Health, College of Health Science, Arsi University, Asella, Ethiopia.
Mosisa Bekele DegefaDepartment of Public Health, College of Health Science, Arsi University, Asella, Ethiopia.
Melkamu AyalewEthiopian Ministry of Health, Addis Ababa, Ethiopia.
Yohannes LakewEthiopian Ministry of Health, Addis Ababa, Ethiopia.
Sileshi GaromaEthiopian Ministry of Health, Addis Ababa, Ethiopia.
Elizabeth Naa Adukwei AdoteAfrican Health Economics and Policy Association (AfHEA), Accra, Ghana.
Daniel Malik AchalaAfrican Health Economics and Policy Association (AfHEA), Accra, Ghana.
Grace Njeri MuriithiAfrican Health Economics and Policy Association (AfHEA), Accra, Ghana.
Chinyere Ojiugo MbachuDepartment of Community Medicine, University of Nigeria, Enugu Campus, Nigeria.
James AkaziliSchool of Public Health, C.K. Tedam University of Technology and Applied Sciences, Navrongo, Ghana.
Chikezie IfeanyiHealth Systems and Development Research Group, Veritas University Abuja Nigeria Catholic Secretariat Abuja, Abuja, Nigeria.
Elias Asfaw ZegeyeHealth Economist, Africa Centers for Disease Control and Prevention (Africa CDC), Division of Health Economics and Financing, Addis Ababa, Ethiopia.
Chijioke O NwosuDepartment of Economics and Finance, University of the Free State, Bloemfontein, South Africa.
John E AtagubaAfrican Health Economics and Policy Association (AfHEA), Accra, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: COVID-19 vaccines are crucial for preventing severe illness from the virus. Despite their effectiveness; vaccine hesitancy, unequal access, and economic disparities hinder vaccination programs across Africa, posing significant challenges in Ethiopia. Method: This scoping review followed the methodological guidelines outlined in the Joanna Briggs Institute Reviewer's and employed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses - Extension for Scoping Reviews (PRISMA-ScR) checklist and explanation to ensure transparency. To analyze the data, we developed tailored search strategies for key databases [HINARI, PubMed, Cochrane, African Journals Online (AJOL), and Science Direct] and gray literature sources. These strategies combined controlled vocabulary and relevant keywords. A descriptive thematic analysis was then employed to identify and categorize the various findings within the included studies. The results are presented in a narrative format, summarizing the key themes and providing a clear and comprehensive overview of the current evidence base. Results and recommendations: A review of 34 Ethiopian studies revealed significant COVID-19 vaccine hesitancy, with rates exceeding 50% in over 40% of the studies. The lowest hesitancy was found in adults from Addis Ababa (19.1%), while the highest rates were seen among healthcare workers in Oromia (69.7%) and pregnant women in Southwest Ethiopia (68.8%). Factors contributing to vaccine hesitancy in Ethiopia include being female, having only primary education, residing in rural areas, younger age, limited knowledge about the vaccine, reduced trust in authorities, and misperceptions about the risk of the virus. To address this challenge effectively, policymakers should prioritize interventions that build public trust, enhance awareness of the vaccine's benefits, and counter misinformation.

Indexed as

COVID-19Ethiopiahesitancyscoping reviewvaccines

Identifiers

PMID40980411
PMCPMC12444891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.